Glioma stem cells: novel data obtained by single-cell sequencing
A Gisina, I Kholodenko, Y Kim, M Abakumov… - International journal of …, 2022 - mdpi.com
Glioma is the most common type of primary CNS tumor, composed of cells that resemble
normal glial cells. Recent genetic studies have provided insight into the inter-tumoral …
normal glial cells. Recent genetic studies have provided insight into the inter-tumoral …
Spatial transcriptomics reveals niche-specific enrichment and vulnerabilities of radial glial stem-like cells in malignant gliomas
Y Ren, Z Huang, L Zhou, P Xiao, J Song, P He… - Nature …, 2023 - nature.com
Diffuse midline glioma-H3K27M mutant (DMG) and glioblastoma (GBM) are the most lethal
brain tumors that primarily occur in pediatric and adult patients, respectively. Both tumors …
brain tumors that primarily occur in pediatric and adult patients, respectively. Both tumors …
Nanomedicines targeting glioma stem cells
Glioblastoma (GBM), classified as a grade IV glioma, is a rapidly growing, aggressive, and
most commonly occurring tumor of the central nervous system. Despite the therapeutic …
most commonly occurring tumor of the central nervous system. Despite the therapeutic …
Human endogenous retrovirus K contributes to a stem cell niche in glioblastoma
AH Shah, SR Rivas, TT Doucet-O'Hare… - The Journal of …, 2023 - Am Soc Clin Investig
Human endogenous retroviruses (HERVs) are ancestral viral relics that constitute nearly 8%
of the human genome. Although normally silenced, the most recently integrated provirus …
of the human genome. Although normally silenced, the most recently integrated provirus …
Kunitz-type protease inhibitor TFPI2 remodels stemness and immunosuppressive tumor microenvironment in glioblastoma
Glioblastoma (GBM) tumors consist of multiple cell populations, including self-renewing
glioblastoma stem cells (GSCs) and immunosuppressive microglia. Here we identified …
glioblastoma stem cells (GSCs) and immunosuppressive microglia. Here we identified …
Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissues
P Yao, P Xiao, Z Huang, M Tang, X Tang, G Yang… - Nature Cancer, 2023 - nature.com
Detecting and targeting precancerous cells in noncancerous tissues is a major challenge for
cancer prevention. Massive stabilization of mutant p53 (mutp53) proteins is a cancer-specific …
cancer prevention. Massive stabilization of mutant p53 (mutp53) proteins is a cancer-specific …
PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition
Z Gao, J Xu, Y Fan, Y Qi, S Wang, S Zhao… - Journal of Experimental …, 2022 - Springer
Background Resistance to temozolomide (TMZ) is a major obstacle to preventing
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
glioblastoma (GBM) recurrence after surgery. Although long noncoding RNAs (lncRNAs) …
CircNDC80 promotes glioblastoma multiforme tumorigenesis via the miR-139-5p/ECE1 pathway
Y Wang, B Wang, F Zhou, K Lv, X Xu, W Cao - Journal of Translational …, 2023 - Springer
Abstract Background Circular RNAs (circRNAs) have been shown to be essential for the
emergence and growth of different cancers. However, further research is required to validate …
emergence and growth of different cancers. However, further research is required to validate …
The multifaceted mechanisms of malignant glioblastoma progression and clinical implications
R Sun, AH Kim - Cancer and Metastasis Reviews, 2022 - Springer
With the application of high throughput sequencing technologies at single-cell resolution,
studies of the tumor microenvironment in glioblastoma, one of the most aggressive and …
studies of the tumor microenvironment in glioblastoma, one of the most aggressive and …
[HTML][HTML] A bioinformatic study of IGFBPs in glioma regarding their diagnostic, prognostic, and therapeutic prediction value
H Liu, T Tang - American Journal of Translational Research, 2023 - ncbi.nlm.nih.gov
Background: It is essential to develop better biomarkers for diagnosis, prediction, and
treating glioma patients to ensure successful clinical outcomes. The clinical application of …
treating glioma patients to ensure successful clinical outcomes. The clinical application of …